Medidata Executives to Drive Industry Dialogue at Bio-IT World and Partnerships With CROs
FOR IMMEDIATE RELEASE
Medidata Executives to Drive Industry Dialogue at
Bio-IT World and Partnerships With CROs
Chief Medical Officer Dr. Ed Ikeguchi, Chief Technology Officer Glen de Vries and VP
of Development Keith Howells to Lead EDC Discussions at Key Industry Events
NEW YORK, NY – March 27, 2006 – Medidata Solutions, a global provider of electronic clinical data capture, management and reporting solutions, today announced the participation of three of its top executives in two key upcoming industry events. Chief Medical Officer Dr. Ed Ikeguchi will be chairing a session at Bio-IT World’s Life Sciences Conference and Expo, to be held April 3–5, 2006 in Boston. At the same time, Vice President of Development Keith Howells will be speaking and Chief Technology Officer Glen de Vries will be leading a panel discussion with Medidata customers at the EDC and Beyond Conference, held in conjunction with the IIR’s Partnerships with CROs, on April 3–5, 2006 in Las Vegas.
Ikeguchi will be chairing a discussion within the E-Clinical Research and Trials track on “Progress on Standards and Interoperability” at the Bio-IT World Life Sciences Conference and Expo on April 4 at 11 a.m. In this presentation, Ikeguchi will lead industry executives in a discussion on various topics including semantic interoperability between clinical research and healthcare, conditioning the industry for an interoperability platform and progress reporting on standards.
At the IIR’s 10th Annual EDC and Beyond event, Howells will present on April 4 at 2:45 p.m. on “EDC Grows Up: Can Your System Scale When All Trials Are Electronic?” Addressing scalability requirements for the broad adoption of EDC, Howells will highlight EDC solutions that have the ability to manage all studies in a single system and support real-time reporting.
On April 5, the second day of the EDC and Beyond conference, de Vries will moderate a panel discussion entitled, “Interfacing with EDC—When Do I Need to Integrate and What’s the Right Way to Do It?” at 3:30 p.m. de Vries will lead the panel that includes Medidata customers as they evaluate architectural approaches to interfacing EDC with up and downstream systems and discuss real-world examples of successful EDC integrations.
At both conferences, Medidata Solutions will be showcasing Rave 5.5, a new version of its clinical data capture, management and reporting solution. Rave 5.5 demonstrations will be held at Medidata’s booths, #147 at the Bio-IT World Life Sciences Conference and Expo and #325 at IIR’s Partnerships for CROs event.
As one of Medidata Solutions' founders and the company’s chief medical officer, Ikeguchi focuses on regulatory affairs and 21 CFR Part 11 and developing strategy in emerging global markets. Prior to forming Medidata Solutions in 2000, Ikeguchi served as assistant professor of clinical urology at Columbia University and has firsthand experience using healthcare technology solutions as a clinical investigator in numerous trials sponsored by both commercial industry and NIH. He has expertise in technologybased process evaluation and value modeling for the pharmaceutical and biotechnology industries. Ikeguchi has secured patents on Medidata Solutions' clinical trial technology and also invented several patented medical devices that have been through the clinical development process.
de Vries, another founder of Medidata Solutions, has filled the role of chief technology officer since 1999. He is the lead architect of the Medidata Rave system, and has grown the research and development team to include top talent from the clinical research community, banking and enterprise resource planning industry. Prior to his work with Medidata Solutions, Glen's pioneering efforts in online physician/patient relationships were featured by The New York Times and drew the attention of the Office of Health and Human Services. He has more than 10 years of experience in medical software development, including electronic health records and consumer-targeted products.
Howells manages the development team at Medidata Solutions and is responsible for both the core Rave product as well as for customer-specific integrations and utilities. In this role, Howells drives the innovation of new features and new technologies into Rave, while providing a smooth upgrade path for existing customers. Howells has dedicated his efforts to the clinical trials business for more than 15 years. In his prior position at Oracle, he helped to establish Oracle Clinical as the dominant back-end data management system, initially as head of the pharmaceutical consulting practice and then as vice president of the pharmaceutical applications development group.
About Bio•IT World Conference + Expo
Bio•IT World Conference + Expo is the leading event to demonstrate how technology is transforming the life sciences throughout all discovery and development processes. Bio•IT World Conference + Expo is designed for life science professionals looking to evaluate and understand advanced solutions that generate, collect and analyze the flood of information being produced by the life sciences industry. Visionaries from the biotechnology, pharmaceutical, healthcare, academic and government markets convene at Bio•IT World Conference + Expo to learn how the latest tools, services and best practices will help revolutionize our health, our environment and our society. For more information, visit
www.bio-itworldexpo.com.
About Partnerships with CROs
Partnerships™ with CROs & Other Outsourcing Providers is organized by the Institute for International Research (IIR), the world's largest conference company. For 13 years running, IIR has provided a knowledge-led networking forum for the CRO industry where senior professionals from outsourcing and clinical groups at pharmaceutical and biotech companies, CROs, niche providers and investigative sites convene to maximize clinical development partnerships. For more information, please visit www.iirusa.com/cropartners.
About Medidata Solutions Worldwide
Medidata Solutions helps the world’s leading pharmaceutical, biotechnology and medical device companies realize the maximum potential value from their clinical research investments. Working with companies large and small, Medidata Solutions helps accelerate the process of bringing life-enhancing treatments to market—on five continents and in more than 70 countries. Innovative process design, technology and services can streamline clinical trials by providing early visibility to clinical data for faster decision-making, optimized resources and lower execution risk. Medidata Solutions’ broad client base and deep clinical experience provide value for the world’s leading pharmaceutical, biotechnology and medical device companies, expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. To learn more about Medidata Solutions, please visit www.mdsol.com.
Contact:
Susan Lombardo
Lois Paul & Partners
781.782.5767
Susan_Lombardo@lpp.com